The Department would always be happy to speak with any other parties in the pharmaceutical sector. It is important to point out that the 180-day period is for the decision from the application through the HTA process to reimbursement. I know there is a bit of a disconnect here. Because something has been EMA-approved, there is an assumption that that consideration is happening in the HSE. That only happens if the drug company makes an application in Ireland and that is not always the case for a lot of different rea…